Quick Takeaways
- Column Group II GP, LP has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $2,613,608.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Column Group II GP, LP
- Location
- San Francisco, CA
- Summary
- The estimated value of insider holdings of Column Group II GP, LP is at least $2,613,608 dollars as of 07 Sep 2021. Column Group II GP, LP is the 10%+ Owner of eFFECTOR Therapeutics, Inc. and owns shares of eFFECTOR Therapeutics, Inc. stock worth about $2.61M.
- Signature
- /s/ The Column Group II GP, LP /s/ James Evangelista, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Column Group II GP, LP and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: eFFECTOR Therapeutics, Inc. ($2,613,608).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Column Group II GP, LP
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EFTR | eFFECTOR Therapeutics, Inc. | 10%+ Owner | $2,613,608 | 25 Aug 2021 |
Insider Transactions Reported by Column Group II GP, LP:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.